4
Changes in Ownership
Ultragenyx Pharmaceutical Inc. Filed Acc 0001193125-26-089111
EVP and Chief Legal Officer sold 8,135 shares at $22.80 ($185,478)
- EVP and Chief Legal Officer acquired 11,137 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Parschauer Karah Herdman · EVP and Chief Legal Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-03-01 | Grant or award : show line 1 in the form | +11,137 | 84,408 | D | ||
| 2026-03-02 | Sale : show line 2 in the form | −8,135 | $22.80 | $185,478 | 76,346 | D |
| Open-market sales · 8,135 sh · avg $22.80 · $185,478 | ||||||
Loading xslF345X05/ownership.xml…